An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma Meeting Abstract


Authors: Abou-Alfa, G. K.; Yoon, J. H.; Modiano, M.; Ryoo, B. Y.; Yau, T.; Freilich, B.; Knox, J.; Ly, M.; Ahmed, H.; Gahir, S.; Niforos, D.; Kowalski, M.; Kelley, R. K.
Abstract Title: An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma
Meeting Title: 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 69
Issue: Suppl. 1
Meeting Dates: 2016 Nov 29-Dec 2
Meeting Location: Munich, Germany
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2016-12-01
Start Page: S22
Language: English
ACCESSION: WOS:000390503500041
PROVIDER: Thomson Reuters Web of Scienceā„¢
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)32646-6
Notes: Meeting Abstract: 46 -- 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 29-DEC 02, 2016 -- Munich, GERMANY -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa
  2. Michele   Ly
    17 Ly